Tony Wang, Research Scientist, Virology, Infectious Disease Research Program | SRI International

Toggle Menu

Tony Wang

Program Director, Virology, Center for Infectious Diseases

Tony Wang, Ph.D., studies the molecular biology and immunology of viruses of global importance (such as HCV, HIV, Dengue, and Zika). His laboratory is also interested in developing antivirals and vaccines. Current research includes investigating how two novel cell signaling proteins mediate HCV entry and developing a new class of entry inhibitor targeting these signaling proteins as a critical component of future anti-HCV cocktails.

As a principal investigator on several National Institutes of Health-funded grants, Wang built research frameworks by assembling productive research teams, developing techniques and reagents, and by securing resources, strong collaborators, and consultants to complete the work.

Wang is a member of the American Association of Immunologists and the American Society for Virology. He has been an ad hoc reviewer, an editorial board member, a scientific program organizer. He has received many honors for his academic work and has published nearly 50 peer-reviewed articles in journals.

Wang has a B.S. in medicine from Beijing Medical University. His Ph.D. in microbiology and immunology are from The Ohio State University. He completed post-doctoral studies in immunology at Howard Hughes Medical Institute at the University of California, Los Angeles, and in mass spectrometry and immunology at Los Alamos National Laboratory.